Request Deal Involvement
T. Rowe Price led a $518m Series B financing round in Eikon Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Bioscribe
or
Principals
bidder
HAREL GROUP
bidder
ABU DHABI INVESTMENT AUTHORITY (ADIA)
bidder
SOROS FUND MANAGEMENT LLC
bidder
HARTFORD HEALTHCARE ENDOWMENT
bidder
CANADA PENSION PLAN INVESTMENT BOARD (CPP INVESTMENTS)
bidder
UC INVESTMENTS
bidder
FORESITE CAPITAL MANAGEMENT LLC
bidder
T. ROWE PRICE GROUP INC
bidder
ECOR1 CAPITAL
bidder
LUX CAPITAL MANAGEMENT
bidder
INNOVATION ENDEAVORS
target
EIKON THERAPEUTICS INC
bidder
SCHRODERS CAPITAL REAL ESTATE
bidder
AME CLOUD VENTURES
bidder
STEPSTONE GROUP
bidder
GENERAL CATALYST PARTNERS
bidder
E15 VC
bidder
THE COLUMN GROUP
bidder
HORIZONS VENTURES LTD
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite